142867-52-5Relevant articles and documents
Optimization of HNO production from N, O - Bis -acylated hydroxylamine derivatives
Sutton, Art D.,Williamson, Morgan,Weismiller, Hilary,Toscano, John P.
supporting information; experimental part, p. 472 - 475 (2012/03/26)
A wide range of N,O-bis-acylated hydroxylamine derivatives with chloro or arenesulfonyl leaving groups, and a related set of N-hydroxy-N-acylsulfonamides, have been synthesized and evaluated for nitroxyl (HNO) production. Mechanistic studies have revealed that the observed aqueous chemistry is more complicated than originally anticipated, and have been used to develop a new series of efficient HNO precursors (4u-4x, 7c-7d) with tunable half-lives.
Bis-Acylated Hydroxylamine Derivatives
-
, (2011/06/24)
The invention provides certain bis-acylated hydroxylamine derivative compounds, pharmaceutical compositions and kits comprising such compounds, and methods of using such compounds or pharmaceutical compositions. In particular, the invention provides methods of using such compounds or pharmaceutical compositions for treating, preventing, or delaying the onset and/or develop of a disease or condition. In some embodiments, the disease or condition is selected from cardiovascular diseases, ischemia, reperfusion injury, cancerous disease, pulmonary hypertension and conditions responsive to nitroxyl therapy.
Prodrugs of Nitroxyl as Inhibitors of Aldehyde Dehydrogenase
Lee, Melinda J. C.,Nagasawa, Herbert T.,Elberling, James A.,DeMaster, Eugene G.
, p. 3648 - 3652 (2007/10/02)
In the preceding paper, analogs of chlorpropamide with an OMe substituent on the sulfonamide nitrogen were shown to inhibit aldehyde dehydrogenase (AlDH), and it was postulated that these compounds were bioactivated by O-demethylation to release nitroxyl